Shantou Special Economic Zone Meiji Pharmaceutical

Shantou Special Economic Zone Meiji Pharmaceutical is a specialized pharmaceutical manufacturer based in China, operating as a key subsidiary of the Japanese firm Meiji Seika Pharma. Established in 1989, the company focuses on the production and commercialization of high-quality anti-infective agents, particularly beta-lactam antibiotics. Its flagship product is Cefditoren pivoxil, marketed under the brand name Meiact, which is widely used for treating various bacterial infections. The company operates advanced manufacturing facilities in the Shantou Special Economic Zone that comply with international Good Manufacturing Practice (GMP) standards, supporting both the domestic Chinese market and export activities. By leveraging Meiji's global expertise in anti-infective research, the company has established itself as a reliable provider of essential antibiotic therapies.